サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1487645

ゲノミクスパーソナライズドヘルス市場：世界の産業分析、規模、シェア、成長、動向、2024-2034年予測

Genomics Personalized Health Market (Technology: NGS Platform, RT-PCR, Microarray, Genetic Analyzer, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

出版日
ページ情報
英文 180 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.87円
ゲノミクスパーソナライズドヘルス市場：世界の産業分析、規模、シェア、成長、動向、2024-2034年予測
出版日: 2024年04月19日
発行: Transparency Market Research
ページ情報: 英文 180 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ゲノミクスパーソナライズドヘルス市場- 調査範囲

TMRの調査レポート「世界のゲノミクスパーソナライズドヘルス市場」は、2024年から2034年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。本レポートでは、2024年を基準年、2034年を予測年として、2018年から2034年までの世界のゲノミクスパーソナライズドヘルス市場の収益と予測を提供します。また、2024年から2034年までの世界のゲノミクスパーソナライズドヘルス市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されました。1次調査では、主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照し、ゲノミクスパーソナライズドヘルス市場を理解しました。

市場スナップショット
2023年の市場規模 91億米ドル
2034年の市場価値 330億米ドル
CAGR 12.2%

本レポートでは、世界のゲノミクスパーソナライズドヘルス市場の競合情勢について掘り下げています。世界のゲノミクスパーソナライズドヘルス市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTは、本レポートで紹介されている世界のゲノミクスパーソナライズドヘルス市場のプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：市場

第4章 市場概要

  • イントロダクション
  • 市場概要
  • 市場力学
  • 市場分析と予測、2020-2034年

第5章 主要洞察

  • パイプライン分析
  • 主要製品・ブランド分析
  • 主要M&A
  • COVID-19パンデミックの産業への影響

第6章 世界市場分析・予測：技術別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：技術別、2020年～2034年
    • NGSプラットフォーム
    • RT-PCRプラットフォーム
    • マイクロアレイ
    • 遺伝子解析装置
    • その他
  • 市場魅力度分析：技術別

第7章 世界市場分析・予測：検査タイプ別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：検査タイプ別、2020年～2034年
    • オンコロジー検査
    • 感染症検査
    • 希少疾患検査
    • 自己免疫疾患検査
    • 産科検査
    • その他
  • 市場魅力度分析：検査タイプ別

第8章 世界市場分析・予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：エンドユーザー別、2020年～2034年
    • 学術・研究機関
    • 診断センター
    • その他
  • 市場魅力度分析：エンドユーザー別

第9章 世界市場分析・予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別、2020年～2034年
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力度分析：地域別

第10章 北米市場の分析と予測

第11章 欧州市場の分析と予測

第12章 アジア太平洋市場の分析と予測

第13章 ラテンアメリカ市場の分析と展望

第14章 中東・アフリカ市場の分析と展望

第15章 競合情勢

  • 市場競合マトリックス（企業階層別・企業規模別）
  • 市場シェア分析：企業別（2023年）
  • 企業プロファイル
    • QIAGEN
    • Illumina, Inc.
    • Thermo Fisher Scientific, Inc.
    • Bio-Rad Laboratories, Inc.
    • Hoffmann-La Roche AG
    • Lonza Group
    • Invitae Corp
    • Genetic Technologies Limited
    • Interleukin Genetics Inc.
    • Eastern Biotech and Life Sciences
    • DNA Genotek Inc.
    • uBiome, Inc.
    • XCode Life Sciences Private Limited
図表

List of Tables

  • Table 01: Global Genomics Personalized Health Market Size (US$ Mn) Forecast, By Technology, 2020-2034
  • Table 02: Global Genomics Personalized Health Market Size (US$ Mn) Forecast, by Test Type, 2020-2034
  • Table 03: Global Genomics Personalized Health Market Size (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 04: Global Genomics Personalized Health Market Size (US$ Mn) Forecast, by Region, 2020-2034
  • Table 05: North America Genomics Personalized Health Market Size (US$ Mn) Forecast, by Country, 2020-2034
  • Table 06: North America Genomics Personalized Health Market Size (US$ Mn) Forecast, By Technology, 2020-2034
  • Table 07: North America Genomics Personalized Health Market Size (US$ Mn) Forecast, by Test Type, 2020-2034
  • Table 08: North America Genomics Personalized Health Market Size (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 09: Europe Genomics Personalized Health Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 10: Europe Genomics Personalized Health Market Size (US$ Mn) Forecast, By Technology, 2020-2034
  • Table 11: Europe Genomics Personalized Health Market Size (US$ Mn) Forecast, by Test Type, 2020-2034
  • Table 12: Europe Genomics Personalized Health Market Size (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 13: Asia Pacific Genomics Personalized Health Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Asia Pacific Genomics Personalized Health Market Size (US$ Mn) Forecast, By Technology, 2020-2034
  • Table 15: Asia Pacific Genomics Personalized Health Market Size (US$ Mn) Forecast, by Test Type, 2020-2034
  • Table 16: Asia Pacific Genomics Personalized Health Market Size (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 17: Latin America Genomics Personalized Health Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 18: Latin America Genomics Personalized Health Market Size (US$ Mn) Forecast, By Technology, 2020-2034
  • Table 19: Latin America Genomics Personalized Health Market Size (US$ Mn) Forecast, by Test Type, 2020-2034
  • Table 20: Latin America Genomics Personalized Health Market Size (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 21: Middle East & Africa Genomics Personalized Health Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Middle East & Africa Genomics Personalized Health Market Size (US$ Mn) Forecast, By Technology, 2020-2034
  • Table 23: Middle East & Africa Genomics Personalized Health Market Size (US$ Mn) Forecast, by Test Type, 2020-2034
  • Table 24: Middle East & Africa Genomics Personalized Health Market Size (US$ Mn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global Genomics Personalized Health Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034
  • Figure 02: Global Genomics Personalized Health Market Revenue (US$ Mn), By Technology, 2023
  • Figure 03: Global Genomics Personalized Health Market Value Share, By Technology, 2023
  • Figure 04: Global Genomics Personalized Health Market Revenue (US$ Mn), by Test Type, 2023
  • Figure 05: Global Genomics Personalized Health Market Value Share, by Test Type, 2023
  • Figure 06: Global Genomics Personalized Health Market Revenue (US$ Mn), by End-user, 2023
  • Figure 07: Global Genomics Personalized Health Market Value Share, by End-user, 2023
  • Figure 08: Global Genomics Personalized Health Market Value Share, by Region, 2023
  • Figure 09: Global Genomics Personalized Health Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 10: Global Genomics Personalized Health Market Value Share Analysis, By Technology, 2023 and 2034
  • Figure 11: Global Genomics Personalized Health Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 12: Global Genomics Personalized Health Market Value Share Analysis, by Test Type, 2023 and 2034
  • Figure 13: Global Genomics Personalized Health Market Attractiveness Analysis, by Test Type, 2024-2034
  • Figure 14: Global Genomics Personalized Health Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 15: Global Genomics Personalized Health Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 16: Global Genomics Personalized Health Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 17: Global Genomics Personalized Health Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 18: North America Genomics Personalized Health Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 19: North America Genomics Personalized Health Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 20: North America Genomics Personalized Health Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 21: North America Genomics Personalized Health Market Value Share Analysis, By Technology, 2023 and 2034
  • Figure 22: North America Genomics Personalized Health Market Value Share Analysis, by Test Type, 2023 and 2034
  • Figure 23: North America Genomics Personalized Health Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 24: North America Genomics Personalized Health Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 25: North America Genomics Personalized Health Market Attractiveness Analysis, by Test Type, 2024-2034
  • Figure 26: North America Genomics Personalized Health Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 27: Europe Genomics Personalized Health Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 28: Europe Genomics Personalized Health Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 29: Europe Genomics Personalized Health Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 30: Europe Genomics Personalized Health Market Value Share Analysis, By Technology, 2023 and 2034
  • Figure 31: Europe Genomics Personalized Health Market Value Share Analysis, by Test Type, 2023 and 2034
  • Figure 32: Europe Genomics Personalized Health Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 33: Europe Genomics Personalized Health Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 34: Europe Genomics Personalized Health Market Attractiveness Analysis, by Test Type, 2024-2034
  • Figure 35: Europe Genomics Personalized Health Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 36: Asia Pacific Genomics Personalized Health Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 37: Asia Pacific Genomics Personalized Health Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 38: Asia Pacific Genomics Personalized Health Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 39: Asia Pacific Genomics Personalized Health Market Value Share Analysis, By Technology, 2023 and 2034
  • Figure 40: Asia Pacific Genomics Personalized Health Market Value Share Analysis, by Test Type, 2023 and 2034
  • Figure 41: Asia Pacific Genomics Personalized Health Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 42: Asia Pacific Genomics Personalized Health Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 43: Asia Pacific Genomics Personalized Health Market Attractiveness Analysis, by Test Type, 2024-2034
  • Figure 44: Asia Pacific Genomics Personalized Health Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 45: Latin America Genomics Personalized Health Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 46: Latin America Genomics Personalized Health Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 47: Latin America Genomics Personalized Health Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 48: Latin America Genomics Personalized Health Market Value Share Analysis, By Technology, 2023 and 2034
  • Figure 49: Latin America Genomics Personalized Health Market Value Share Analysis, by Test Type, 2023 and 2034
  • Figure 50: Latin America Genomics Personalized Health Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 51: Latin America Genomics Personalized Health Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 52: Latin America Genomics Personalized Health Market Attractiveness Analysis, by Test Type, 2024-2034
  • Figure 53: Latin America Genomics Personalized Health Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 54: Middle East & Africa Genomics Personalized Health Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 55: Middle East & Africa Genomics Personalized Health Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 56: Middle East & Africa Genomics Personalized Health Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 57: Middle East & Africa Genomics Personalized Health Market Value Share Analysis, By Technology, 2023 and 2034
  • Figure 58: Middle East & Africa Genomics Personalized Health Market Value Share Analysis, by Test Type, 2023 and 2034
  • Figure 59: Middle East & Africa Genomics Personalized Health Market Value Share Analysis, by End-user, 2023 and 2034
  • Figure 60: Middle East & Africa Genomics Personalized Health Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 61: Middle East & Africa Genomics Personalized Health Market Attractiveness Analysis, by Test Type, 2024-2034
  • Figure 62: Middle East & Africa Genomics Personalized Health Market Attractiveness Analysis, by End-user, 2024-2034
目次
Product Code: TMRGL12197

Genomics Personalized Health Market - Scope of Report

TMR's report on the global genomics personalized health market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global genomics personalized health market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global genomics personalized health market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the genomics personalized health market.

Market Snapshot
Market Value in 2023US$ 9.1 Bn
Market Value in 2034US$ 33 Bn
CAGR12.2%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global genomics personalized health market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global genomics personalized health market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global genomics personalized health market.

The report delves into the competitive landscape of the global genomics personalized health market. Key players operating in the global genomics personalized health market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global genomics personalized health market profiled in this report.

Key Questions Answered in Global genomics personalized health Market Report:

  • What is the sales/revenue generated by genomics personalized health across all regions during the forecast period?
  • What are the opportunities in the global genomics personalized health market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Genomics Personalized Health Market - Research Objectives and Research Approach

The comprehensive report on the global genomics personalized health market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global genomics personalized health market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global genomics personalized health market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Genomics Personalized Health Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Genomics Personalized Health Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product /Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Genomics Personalized Health Market Analysis and Forecast, By Technology

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, By Technology, 2020-2034
    • 6.3.1. NGS Platform
    • 6.3.2. RT-PCR
    • 6.3.3. Microarray
    • 6.3.4. Genetic Analyzer
    • 6.3.5. Others
  • 6.4. Market Attractiveness Analysis, By Technology

7. Global Genomics Personalized Health Market Analysis and Forecast, by Test Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Test Type, 2020-2034
    • 7.3.1. Oncology Testing
    • 7.3.2. Infectious Disease Testing
    • 7.3.3. Orphan Disease Testing
    • 7.3.4. Autoimmune Disease Testing
    • 7.3.5. Obstetrics Testing
    • 7.3.6. Others
  • 7.4. Market Attractiveness Analysis, by Test Type

8. Global Genomics Personalized Health Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2020-2034
    • 8.3.1. Academics & Research Institutes
    • 8.3.2. Diagnostic Centers
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Genomics Personalized Health Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2020-2034
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Genomics Personalized Health Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, By Technology, 2020-2034
    • 10.3.1. NGS Platform
    • 10.3.2. RT-PCR
    • 10.3.3. Microarray
    • 10.3.4. Genetic Analyzer
    • 10.3.5. Others
  • 10.4. Market Value Forecast, by Test Type, 2020-2034
    • 10.4.1. Oncology Testing
    • 10.4.2. Infectious Disease Testing
    • 10.4.3. Orphan Disease Testing
    • 10.4.4. Autoimmune Disease Testing
    • 10.4.5. Obstetrics Testing
    • 10.4.6. Others
  • 10.5. Market Value Forecast, by End-user, 2020-2034
    • 10.5.1. Academics & Research Institutes
    • 10.5.2. Diagnostic Centers
    • 10.5.3. Others
  • 10.6. Market Value Forecast, by Country, 2020-2034
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Technology
    • 10.7.2. By Test Type
    • 10.7.3. By End-user
    • 10.7.4. By Country

11. Europe Genomics Personalized Health Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, By Technology, 2020-2034
    • 11.3.1. NGS Platform
    • 11.3.2. RT-PCR
    • 11.3.3. Microarray
    • 11.3.4. Genetic Analyzer
    • 11.3.5. Others
  • 11.4. Market Value Forecast, by Test Type, 2020-2034
    • 11.4.1. Oncology Testing
    • 11.4.2. Infectious Disease Testing
    • 11.4.3. Orphan Disease Testing
    • 11.4.4. Autoimmune Disease Testing
    • 11.4.5. Obstetrics Testing
    • 11.4.6. Others
  • 11.5. Market Value Forecast, by End-user, 2020-2034
    • 11.5.1. Academics & Research Institutes
    • 11.5.2. Diagnostic Centers
    • 11.5.3. Others
  • 11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Technology
    • 11.7.2. By Test Type
    • 11.7.3. By End-user
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Genomics Personalized Health Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, By Technology, 2020-2034
    • 12.3.1. NGS Platform
    • 12.3.2. RT-PCR
    • 12.3.3. Microarray
    • 12.3.4. Genetic Analyzer
    • 12.3.5. Others
  • 12.4. Market Value Forecast, by Test Type, 2020-2034
    • 12.4.1. Oncology Testing
    • 12.4.2. Infectious Disease Testing
    • 12.4.3. Orphan Disease Testing
    • 12.4.4. Autoimmune Disease Testing
    • 12.4.5. Obstetrics Testing
    • 12.4.6. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Technology
    • 12.6.2. By Test Type
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Genomics Personalized Health Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, By Technology, 2020-2034
    • 13.3.1. NGS Platform
    • 13.3.2. RT-PCR
    • 13.3.3. Microarray
    • 13.3.4. Genetic Analyzer
    • 13.3.5. Others
  • 13.4. Market Value Forecast, by Test Type, 2020-2034
    • 13.4.1. Oncology Testing
    • 13.4.2. Infectious Disease Testing
    • 13.4.3. Orphan Disease Testing
    • 13.4.4. Autoimmune Disease Testing
    • 13.4.5. Obstetrics Testing
    • 13.4.6. Others
  • 13.5. Market Value Forecast, by End-user, 2020-2034
    • 13.5.1. Academics & Research Institutes
    • 13.5.2. Diagnostic Centers
    • 13.5.3. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Technology
    • 13.7.2. By Test Type
    • 13.7.3. By End-user
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Genomics Personalized Health Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, By Technology, 2020-2034
    • 14.3.1. NGS Platform
    • 14.3.2. RT-PCR
    • 14.3.3. Microarray
    • 14.3.4. Genetic Analyzer
    • 14.3.5. Others
  • 14.4. Market Value Forecast, by Test Type, 2020-2034
    • 14.4.1. Oncology Testing
    • 14.4.2. Infectious Disease Testing
    • 14.4.3. Orphan Disease Testing
    • 14.4.4. Autoimmune Disease Testing
    • 14.4.5. Obstetrics Testing
    • 14.4.6. Others
  • 14.5. Market Value Forecast, by End-user, 2020-2034
    • 14.5.1. Academics & Research Institutes
    • 14.5.2. Diagnostic Centers
    • 14.5.3. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Technology
    • 14.7.2. By Test Type
    • 14.7.3. By End-user
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2023)
  • 15.3. Company Profiles
    • 15.3.1. QIAGEN
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Illumina, Inc.
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Thermo Fisher Scientific, Inc.
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Bio-Rad Laboratories, Inc.
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Hoffmann-La Roche AG
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Lonza Group
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Invitae Corp
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Genetic Technologies Limited
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Interleukin Genetics Inc.
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Financial Overview
      • 15.3.9.5. Strategic Overview
    • 15.3.10. Eastern Biotech and Life Sciences
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. SWOT Analysis
      • 15.3.10.4. Financial Overview
      • 15.3.10.5. Strategic Overview
    • 15.3.11. DNA Genotek Inc.
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Product Portfolio
      • 15.3.11.3. SWOT Analysis
      • 15.3.11.4. Financial Overview
      • 15.3.11.5. Strategic Overview
    • 15.3.12. uBiome, Inc.
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Product Portfolio
      • 15.3.12.3. SWOT Analysis
      • 15.3.12.4. Financial Overview
      • 15.3.12.5. Strategic Overview
    • 15.3.13. XCode Life Sciences Private Limited
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Product Portfolio
      • 15.3.13.3. SWOT Analysis
      • 15.3.13.4. Financial Overview
      • 15.3.13.5. Strategic Overview